Molecular architecture and diversity of StopGo/2A translational recoding
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2528667123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Xueyan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom. Hauptthemen laut MEDLINE: Foot-and-Mouth Disease Virus, Viral Proteins, Protein Biosynthesis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Molecular Biology Organization (EMBO), Wellcome Trust (WT), UKRI | Medical Research Council (MRC).
Abstract (Originalsprache)
Viral 2A sequences trigger a cotranslational peptide bond formation “skipping” event, termed “StopGo,” to generate two separate proteins from a single open reading frame without classical termination. To investigate the mechanism of StopGo, we determined the cryo-EM structure of a mammalian ribosome positioned at the foot-and-mouth disease virus 2A (F2A) site. The structure shows how interactions between the F2A nascent chain (NC) and the ribosomal exit tunnel induce a conformational change in the peptidyl transferase center that precludes further translation elongation but instead pre-exposes the P-tRNA:F2A-NC ester bond for hydrolysis and NC release. Additionally, we bioinformatically characterized variation and host association across nearly 10,000 StopGo sequences identified in virus genomes. We expanded the canonical core motif to (D/G/C/N)(V/I)ExNPGP and identified additional rare but functional variants. We also revealed several distinct upstream motifs that we showed biochemically to be important for StopGo activity. Interestingly, although StopGo is known to be functionally active in plants, we found no evidence for natural utilization of StopGo by plant viruses. Overall, these findings provide valuable insights into a unique translation recoding mechanism, and lay foundations for further optimization of multigene expression in biotechnology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom.
- School of Biochemistry and Cell Biology, University College Cork, Cork T12 XF62, Ireland.
- Department of Pathology/Division of Virology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.
ORCID-Profile: Xueyan Li, Philipp K Zuber, Gary Loughran, John F Atkins
Förderung
- European Molecular Biology Organization (EMBO)
- Wellcome Trust (WT)
- UKRI | Medical Research Council (MRC)
- Irish Research Council (IrishResearch)
- Deutsche Akademie der Naturforscher Leopoldina - Nationale Akademie der Wissenschaften (German National Academy of Sciences)
Zitieren
APA
Li, X., Zuber, P. K., Loughran, G., Bhatt, P. R., Alquraish, F., Ramakrishnan, V., Firth, A. E., & Atkins, J. F. (2026). Molecular architecture and diversity of StopGo/2A translational recoding. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2528667123
Vancouver
Li X, Zuber PK, Loughran G, Bhatt PR, Alquraish F, Ramakrishnan V, et al. Molecular architecture and diversity of StopGo/2A translational recoding. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2528667123
BibTeX
@article{Li2026,
author = {Li, Xueyan and Zuber, Philipp K and Loughran, Gary and Bhatt, Pramod R and Alquraish, Fatema and Ramakrishnan, V and Firth, Andrew E and Atkins, John F},
title = {Molecular architecture and diversity of StopGo/2A translational recoding},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2528667123}
}
EUVIMED